Table 2.
Change in HRQOL after intervention compared to baseline in the study patients
| SF-36 Domains | Baseline | Post-Intervention | Mean Difference | p-value* | |||
|---|---|---|---|---|---|---|---|
| Mean | Median | Mean | Median | ||||
| PSC | Physical function | 74.2 | 80 (0–100) | 90.9 | 95 (0–100) | 16.7 | < 0.001 |
| Physical role | 78.7 | 100 (0–100) | 87.7 | 100 (0–100) | 9 | 0.003 | |
| Body pain | 69.4 | 70 (0–100) | 82.7 | 90 (0–100) | 13.3 | < 0.001 | |
| General health | 58.4 | 60 (5–100) | 72.7 | 75 (20–100) | 14.3 | < 0.001 | |
| MSC | Vitality | 49.8 | 50 (0–100) | 65.5 | 70 (0–100) | 15.7 | < 0.001 |
| Social function | 74.7 | 75 (0–100) | 85.8 | 100 (0–100) | 11.1 | < 0.001 | |
| Emotional role | 72.7 | 100 (0–100) | 82.7 | 100 (0–100) | 10 | 0.007 | |
| Mental health | 63.1 | 64 (12–100) | 59.9 | 63 (0–80) | −3.2 | 0.11 | |
| Health Transition | 40.3 | 50 (0–100) | 78.8 | 75 (0–100) | 38.5 | < 0.001 | |
* the results were similar when compared using parametric test (mean) or non-parametric test (median). The values reported are from Wilcoxon paired test